Structural basis for the haemotoxicity of dapsone: The importance of the sulphonyl group

Toxicology

Volumn 117, Issue 1, 1997, Pages 1-11

  Mahmud, R ^a,c   Tingle, M D ^a   Maggs, J L ^a   Cronin, M T D ^b   Dearden, J C ^b   Park, B K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Aniline; Dapsone; Methaemoglobin

Indexed keywords

ANILINE DERIVATIVE; AROMATIC AMINE; DAPSONE; FUNCTIONAL GROUP;

ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME; MALE; METHEMOGLOBINEMIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DAPSONE; HEMATOPOIETIC SYSTEM; HUMANS; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; SULFONIC ACIDS;

ANIMALIA;

EID: 0031567002     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(96)03548-2     Document Type: Article

References (44)

1. Ashby, J. and Tennant, R.W. (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257, 229-306.
2. Bailey, E., Brooks, A.G., Bird, I., Farmer, P.B. and Street, B. (1990) Monitoring exposure to 4,4′-methylenedianiline by the gas chromatography-mass spectrometry determination of adducts to haemoglobin. Anal. Biochem. 190, 175-181.
3. Boersma, M.G., Cnubben, N.H.P., van Berkel, W.J.H., Blom, M., Vervoort. J. and Rietjens, I.M.C.M. (1993) Role of cytochromes P-450 and flavin-containing monooxygenase in the biotransformation of 4-fluoro-N-methylaniline. Drug Metab. Dispos. 21, 218-230.
4. Cnubben, N.H.P. Vervoort, J., Boersma, M.G. and Rietjens, A.M.C.M. (1995) The effect of varying halogen substituent patterns on the cytochrome P450 catalysed dehalogenation of 4-halogenated anilines to 4-aminophenol metabolites. Biochem. Pharmacol. 49 1235-1248.
5. Coleman, M.D. (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patience tolerance. Br. J. Dermatol. 129, 507-513.
6. Coleman, M.D. and Jacobus, D.P. (1993) Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. Biochem. Pharmacol. 45, 1027-1033.
7. Coleman, M.D., Tingle, M.D.. Winn, M.J. and Park, B.K. (1990) Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat. J. Pharm. Pharmacol. 42, 698-703.
8. Coleman, M.D., Tingle, M.D., Hussain, F., Storr, R.C. and Park, B.K. (1991) An investigation into the haematological toxicity of structural analogues of dapsone in vivo and in vitro. J. Pharm. Pharmacol. 43, 779-784.
9. Colwell. W.T., Chan, G., DeGraw, J.I. and Peters, J.H. (1974) Potential antileprotic agents. Inhibition of a model mycobacterial system by diaryl sulfones. J. Med. Chem. 17, 142-144.
10. Cucinell, S.A., Israili. Z.H. and Dayton, P.G. (1972) Microsomal N-oxidation of dapsone as a cause of methaemoglobin formation in human red cells. Am. J. Trop. Med. Hyg. 21, 322-387.
11. Daly, J.W.. Guroff. G., Udenfriend, S and Witkop, B. (1968) Hydroxylation of alkyl-and halogen-substituted anilines and acetanilides by microsomal hydroxylases. Biochem. Pharmacol. 17, 31-36.
12. Dewar, M.J.S., Zoebisch, E.G., Healy, E.F. and Stewart, J.J.P. (1985) A new general purpose quantum chemical mechanical molecular model. J. Am. Chem. Soc. 107, 3902-3909.
13. Ebner, T. and Burchell, B. (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab. Dispos. 21, 50-55.
14. Eyer, P. (1991) Activation of aromatic amines by oxyhaemoglobin. In: P. Hlavica and L.A. Damani (Eds), N-Oxidation of Drugs. Biochemistry, Pharmacology and Toxicology. Chapman & Hall, London, pp. 371-391.
15. Eyer, P. and Ascherl, M. (1987) Reactions of para-substituted nitrosobenzenes with human hemoglobin. Biol. Chem. Hoppe-Seyler 368, 285-294.
16. Ford, G.P. and Herman, P.S. (1992) Relative stabilities of nitrenium ions derived from polycyclic aromatic amines. Relationship to mutagenicity. Chem.-Biol. Interact. 81, 1-18.
17. Gill, H.J., Tingle, M.D. and Park, B.K. (1995) N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity. Br. J. Clin. Pharmacol. 40, 531-538.
18. Golly, I. and Hlavica, P. (1992) Chemical modification of lysine residues in cytochrome-P4501m2 (P450IIB4) - influence on heme liganding of arylamines. Arch. Biochem. Biophys. 292, 287-294.
19. Gonzalez, F.J. (1990) Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 45, 1-38.
20. Hansch, C. and Leo, A. (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York.
21. Harrison, J.H. and Jollow, D.J. (1986) Role of aniline metabolites in aniline-induced haemolytic anaemia. J. Pharmacol. Exp. Ther. 238, 1045-1054.
22. Hjelm, M. and DeVerdier, C.H. (1965) Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz-body formation induced by 4,4′-diaminodiphenylsulphone. Biochem. Pharmacol. 14, 1119-1128.
23. Israili, Z.H., Cucinell, S.A., Vaught, J., Davis, E., Lesser, J.M. and Dayton, P.G. (1973) Studies of the metabolism of dapsone in man and experimental animals: formulation of N-hydroxy metabolites. J. Pharmacol. Exp. Ther. 187, 138-151.
24. Kalopissis, G. (1991) Structure-activity relationships of aromatic amines in the Ames Salmonella typhimurium assay. Mutat. Res. 246, 45-66.
25. Kim, K.H. (1991) Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase. J. Pharm. Sci. 80, 966-970.
26. oct values of chlorosubstituted benzenes and toluenes and anilines by high performance liquid chromatography on ODS silica. J. Chromatogr. 178, 559-565.
27. Koymans, L., Donné-op Den Kelder, G.M., TeKoppele, J.M. and Vermeulen, N.P.E. (1993) Generalized cytochrome P450-mediated oxidation and oxygenation reactions in aromatic substrates with activated N-H. O-H, C-H or S-H substituents. Xenobiotica 23, 633-648.
28. Kramer, P.A., Glader, B.E. and Li, T-K. (1972) Mechanism of methaemoglobin formation by diphenylsulfones. Effect of 4-amino-4′-hydroxy-aminodiphenylsulfone and other p-substituted derivatives. Biochem. Pharmacol. 21, 1265-1274.
29. Martin, M.A., Cox, P.H., Beck, K., Styer, C.M. and Beall, G.N. (1992) A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch. Intern. Med. 152, 523-528.
30. May. D.G., Porter, J.A., Uetrecht, J.P., Wilkinson, G.R. and Branch, R.A. (1990) The contribution of N-hydroxylation to dapsone pharmacokinetics in normal subjects. Clin. Pharmacol. Ther. 48, 619-627.
31. McLean, S., Starmer, G.A. and Thomas, J. (1969) Methaemoglobin formation by aromatic amines. J. Pharm. Pharmacol. 21, 441-450.
32. Mitra, A.K., Thummel, K.E., Kalhorn, T.F.. Kharash, E.D., Unadkat, J.D. and Slattery, J.T. (1995) Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin. Pharmacol. Ther. 58, 556-566.
33. Sabbioni, G. (1992) Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation. Chem.-Biol. Interact. 81, 91-117.
34. Salem, Z., Murray, T. and Yunis, A.A. (1981) The nitroreduction of chloramphenicol by human liver tissue. J. Lab. Clin. Med. 97, 881-886
35. Saxena, M., Saxena, A.K., Chandra. R.S., Sen, A.B., Anand. N., Seydel, J.K. and Wiese, M. (1989) Studies on 2,3,-N,N′-substituted 4,4′-diaminodiphenylsulphones as potential antimalarial agents. Arzneim.-Forsch./Drug. Res. 39, 1081-1084.
36. Tingle, M.D. and Park, B.K. (1993) The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias. Br. J. Clin. Pharmacol. 36, 31-38.
37. Tingle, M.D., Coleman, M.D. and Park, B.K. (1990) Investigation into the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment test system. Br. J. Clin. Pharmacol. 30, 829-838.
38. Tingle, M.D., Jewell, H., O'Neill, P.M. and Park, B.K. (1995) The effect of fluorine substitution the bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro. Biochem. Pharmacol. 50, 1113-1119.
39. Uehleke, H. and Tabarelli, S. (1973) N-Hydroxylation of 4,4′-diaminodiphenyl-sulfone (dapsone) by liver microsomes and in dogs and humans. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 55-68.
40. Uetrecht, J., Zahid, N., Shear, N.H. and Biggar, W.D. (1988) Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. J. Pharmacol. Exp. Ther. 245, 274-279.
41. Vage, C. and Svensson, C.K. (1994) Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1. Drug Metab. Dispos. 22. 572-577.
42. Vinter, J.G., Davis, A. and Sanders, M.R. (1987) Strategic approaches to drug design. Integrated software framework for molecular modelling. J. Comp.-Aided Mol. Des. 1, 31-51.
43. Wiese, M., Seydel, J.K., Pieper, H., Krüger, G., Noll, K.R. and Keck, J. (1987) Multiple regression analysis of antimalarial activities of sulphones and sulphonamides in cell-free systems and principal component analysis to compare with antibacterial activities. Quant. Struct.-Act. Relatsh. 6, 164-172.
44. You, Z.. Brezzell, M.D., Das, S.K., Hooberman, B.H. and Sinsheimer, J.E. (1994) Substituent effects on the in vitro and in vivo genotoxicity of 4-aminobiphenyl and 4-aminostilbene derivatives. Mutat. Res. 320, 45-48.